THE ALTASCIENTIST

A scientific journal by Altasciences in which we delve deep into the processes, challenges, trends, and innovations in drug development.

ISSUE NO. 19 — Hallucinogens, Psychedelics, Entactogens: Challenges Associated With Schedule 1 Therapeutic Development

The Altascientist

ISSUE NO. 19 — Hallucinogens, Psychedelics, Entactogens: Challenges Associated With Schedule 1 Therapeutic Development

Sep 10, 2021

ISSUE NO. 18 — Planning Your First-in-Human Trial

The Altascientist

ISSUE NO. 18 — Planning Your First-in-Human Trial

Aug 27, 2021

ISSUE NO. 17 — Maximizing Drug Formulation for First-in-Human Trials

The Altascientist

ISSUE NO. 17 — Maximizing Drug Formulation for First-in-Human Trials

May 5, 2021

ISSUE NO. 16 — Microsampling in Drug Development

The Altascientist

ISSUE NO. 16 — Microsampling in Drug Development

Dec 15, 2020

ISSUE NO. 15 — COVID-19 Response (Special Edition)

The Altascientist

ISSUE NO. 15 — COVID-19 Response (Special Edition)

Oct 21, 2020

ISSUE NO. 14 — Central Nervous System

The Altascientist

ISSUE NO. 14 — Central Nervous System

Aug 17, 2020

ISSUE NO. 13 — Safety Pharmacology Studies Review — A Review

The Altascientist

ISSUE NO. 13 — Safety Pharmacology Studies Review — A Review

Jun 3, 2020